Bio Details

Ms. Rielly-Gauvin is currently Vice President of Global Commercial Development at AbbVie and brings 20 years of diverse pharmaceutical industry experience to Liquidia’s Board. At AbbVie, she is responsible for developing the strategic commercial direction of key compounds in the company’s pipeline across core therapeutic areas in Immunology, Oncology, Neuroscience and Specialty. Previously, Ms. Rielly-Gauvin worked in the Johnson & Johnson family of companies in commercial, medical affairs and research capacities, including Vice President and General Manager for the Janssen Commercial CNS organization. She holds a B.S. in Chemistry from Simmons College and an MBA in Economics from Rutgers University.